Traders Buy Large Volume of Put Options on ARK Genomic Revolution ETF (BATS:ARKG)

ARK Genomic Revolution ETF (BATS:ARKG) saw unusually large options trading activity on Wednesday. Traders bought 79,250 put options on the stock. This is an increase of approximately 700% compared to the average volume of 9,906 put options.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in the stock. National Bank of Canada FI grew its holdings in ARK Genomic Revolution ETF by 28.4% during the 3rd quarter. National Bank of Canada FI now owns 4,155 shares of the company’s stock worth $106,000 after acquiring an additional 920 shares in the last quarter. IHT Wealth Management LLC bought a new stake in shares of ARK Genomic Revolution ETF in the 3rd quarter valued at about $203,000. Sanctuary Advisors LLC bought a new stake in shares of ARK Genomic Revolution ETF in the 2nd quarter valued at about $222,000. Hilltop Holdings Inc. bought a new stake in shares of ARK Genomic Revolution ETF in the 3rd quarter valued at about $237,000. Finally, Choreo LLC bought a new stake in shares of ARK Genomic Revolution ETF in the 2nd quarter valued at about $314,000.

ARK Genomic Revolution ETF Trading Down 0.1 %

ARKG stock opened at $25.57 on Friday. The business has a 50 day moving average of $24.82 and a 200-day moving average of $25.00.

ARK Genomic Revolution ETF Company Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.